These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31235366)

  • 1. Implantation of Left Ventricular Assist Device Results in Immediate Improvement of Glucose Metabolism in Patients With and Without Diabetes Mellitus.
    Goetz ME; Charnigo R; Guglin M
    Heart Lung Circ; 2020 Jun; 29(6):931-935. PubMed ID: 31235366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurohormonal regulation and improvement in blood glucose control: reduction of insulin requirement in patients with a nonpulsatile ventricular assist device.
    Koerner MM; El-Banayosy A; Eleuteri K; Kline C; Stephenson E; Pae W; Ghodsizad A
    Heart Surg Forum; 2014 Apr; 17(2):E98-102. PubMed ID: 24808450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Diabetes Mellitus on Outcomes in Patients Supported With Left Ventricular Assist Devices: A Single Institutional 9-Year Experience.
    Asleh R; Briasoulis A; Schettle SD; Tchantchaleishvili V; Pereira NL; Edwards BS; Clavell AL; Maltais S; Joyce DL; Joyce LD; Daly RC; Kushwaha SS; Stulak JM
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular assist device implantation improves glycaemic control: a systematic review and meta-analysis.
    Patel N; Gluck JA; Radojevic J; Coleman CI; Baker WL
    ESC Heart Fail; 2018 Dec; 5(6):1141-1149. PubMed ID: 30052326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive Impact of Continuous-Flow Left Ventricular Assist Device Implantation on Glycemic Control in Patients with Type 2 Diabetes Mellitus and Advanced Chronic Systolic Heart Failure.
    Yen DC; Watson MH; Burgess LD; Kuchibhatla M; Patel CB; Campbell KB; Vora AK
    Pharmacotherapy; 2016 Dec; 36(12):1210-1216. PubMed ID: 27779786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent risk factors for ICU mortality after left ventricular assist device implantation.
    Piffard M; Nubret-Le Coniat K; Simon O; Leuillet S; Rémy A; Barandon L; Ouattara A
    Artif Organs; 2020 Feb; 44(2):153-161. PubMed ID: 31318978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices.
    Uriel N; Naka Y; Colombo PC; Farr M; Pak SW; Cotarlan V; Albu JB; Gallagher D; Mancini D; Ginsberg HN; Jorde UP
    Eur J Heart Fail; 2011 Feb; 13(2):195-9. PubMed ID: 21098576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Impact of Diabetes Mellitus on Short-Term Outcomes andIn-Hospital Mortality of Cardiac Mechanical Support with Left Ventricular Assist Device (LVAD): A Retrospective Study from a National Database.
    Yassin AS; Subahi A; Adegbala O; Abubakar H; Akintoye E; Ahmed A; Ismail A; Elhag A; Kambal A; Alade A; Shokr M; Weinberger J; Levine D; Afonso L
    Cardiovasc Revasc Med; 2019 Oct; 20(10):883-886. PubMed ID: 30578171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in glycemic control after left ventricular assist device implantation in advanced heart failure patients with diabetes mellitus.
    Choudhary N; Chen L; Kotyra L; Wittlin SD; Alexis JD
    ASAIO J; 2014; 60(6):675-80. PubMed ID: 25232763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in blood glucose control in patients with diabetes after implantation of left ventricular assist devices.
    Guglin M; Maguire K; Missimer T; Faber C; Caldeira C
    ASAIO J; 2014; 60(3):290-3. PubMed ID: 24614357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory Support.
    Kyriakopoulos CP; Taleb I; Tseliou E; Sideris K; Hamouche R; Maneta E; Nelson M; Krauspe E; Selko S; Visker JR; Dranow E; Goodwin ML; Alharethi R; Wever-Pinzon O; Fang JC; Stehlik J; Selzman CH; Hanff TC; Drakos SG
    J Am Heart Assoc; 2024 Jul; 13(14):e032936. PubMed ID: 38989825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Diabetes Mellitus a Risk Factor for Poor Outcomes after Left Ventricular Assist Device Placement?
    Mohamedali B; Yost G; Bhat G
    Tex Heart Inst J; 2017 Apr; 44(2):115-119. PubMed ID: 28461796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left Ventricular Device Implantation Impacts on Hospitalisation Rates, Length of Stay and Out of Hospital Time.
    Prichard R; Kershaw L; Goodall S; Davidson P; Newton P; McNeil F; Homer T; Hayward C
    Heart Lung Circ; 2018 Jun; 27(6):708-715. PubMed ID: 28888837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-Type Natriuretic Peptide Levels Predict Ventricular Arrhythmia Post Left Ventricular Assist Device Implantation.
    Hellman Y; Malik AS; Lin H; Shen C; Wang IW; Wozniak TC; Hashmi ZA; Pickrell J; Jani M; Caccamo MA; Gradus-Pizlo I; Hadi A
    Artif Organs; 2015 Dec; 39(12):1051-5. PubMed ID: 25864448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical circulatory support improves diabetic control in patients with advanced heart failure.
    Mohamedali B; Yost G; Bhat G
    Eur J Heart Fail; 2014 Oct; 16(10):1120-4. PubMed ID: 25298334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
    Radovancevic B; Vrtovec B; de Kort E; Radovancevic R; Gregoric ID; Frazier OH
    J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increases in Serum Autoantibodies After Left Ventricular Assist Device Implantation.
    Grosman-Rimon L; Ajrawat P; Lioe J; Tumiati LC; Rao V; Billia F; Chruscinski A
    J Card Fail; 2019 Apr; 25(4):301-306. PubMed ID: 30630065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation.
    Vest AR; Mistak SM; Hachamovitch R; Mountis MM; Moazami N; Young JB
    J Card Fail; 2016 Oct; 22(10):789-96. PubMed ID: 26924520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of left ventricular assist device on diabetes management: an evaluation through case analysis and clinical impact.
    Subauste AR; Esfandiari NH; Qu Y; Oral EA; Aaronson KD; Pagani FD; Gianchandani RG
    Hosp Pract (1995); 2014 Aug; 42(3):116-22. PubMed ID: 25255413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Implications of Respiratory Failure in Patients Receiving Durable Left Ventricular Assist Devices for End-Stage Heart Failure.
    Miller PE; Caraballo C; Ravindra NG; Mezzacappa C; McCullough M; Gruen J; Levin A; Reinhardt S; Ali A; Desai NR; Ahmad T
    Circ Heart Fail; 2019 Nov; 12(11):e006369. PubMed ID: 31707800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.